Asal Rahimi M.D., M.S.

Chief Breast Radiation UTSW, Breast SPBI, SCCC Medical Director of Clinical Trials Office, Associate Vice Chair of Program Development Tweets are my own

[Asal Rahimi M.D., M.S. @AsalRahimiMD]

Grateful to see our Phase I Ablative Preop Single Fraction Radiation Breast Cancer Trial, published in JAMA Network Open.

https://t.co/WxT0t1LUB3

Main Outcome:
30-38Gy ONE fraction pre-op RT led to 72% pCR Rate/ 92% npCR+pCR 🚀

🧵1/4

[UTSW Radiation Oncology @UTSW_RadOnc]

Chelsea Bolton, one of our recent interns, will present her Phase II GammaPod 5-Fraction Trial abstract at @ASTRO_org later this year. Her study shows comparable cosmetic outcomes across racial and age groups after dose-escalated S-PBI. It will also be published in @IJROBP.

[Asal Rahimi M.D., M.S. @AsalRahimiMD]

@UTSW_RadOnc @ASTRO_org @IJROBP Great job Chelsea !

[Asal Rahimi M.D., M.S. @AsalRahimiMD]

@KoneruMd @imrtlee @ASTRO_org Amazing and congratulations! Sounds like important data that will be important for the field of rad onc. Looking forward to it!

[UTSW Radiation Oncology @UTSW_RadOnc]

Our Ethos Adaptive Radiation Therapy Training Course was a huge success! Attendees learned to personalize cancer treatment in real time, practiced planning workflows, and simulated treatment with expert guidance to bring advanced care back to their clinics.

[Asal Rahimi M.D., M.S. @AsalRahimiMD]

@StephenChunMD @UChicagoRadonc @NRGonc @ASTRO_org @UTMDAnderson @PrajnanDasMD @ACKoongMDPhD @PSchlembachMD @rweichselbaum @IBCradiation Congratulations!!

[Asal Rahimi M.D., M.S. @AsalRahimiMD]

@jfcdrr @DavidSherMD @UTSW_RadOnc @DaveParsonsPhD Soon!

[Asal Rahimi M.D., M.S. @AsalRahimiMD]

The manuscript under preparation. authors includes: Shanshan Tang, Justin Visak, Tingliang Zhuang, Chang-Shiun Lin, Chien-Yi Liao, Mona Arbab, Sean Domal, Narine Wandrey, Cynthia Tye, Prasanna Alluri, David Sher, Shahed Badiyan, Asal Rahimi, Mu-Han Lin, and David Parsons.

[Asal Rahimi M.D., M.S. @AsalRahimiMD]

Our team delivered the first simulation-omitted (So-Fast) breast treatment on the Ethos today. Kudos to our physics team led by Dr David Parsons for doing the heavy lifting to reduce time commitments for our patients.

[Asal Rahimi M.D., M.S. @AsalRahimiMD]

This study explores a faster way to deliver RT for breast cancer, where planning and treatment are completed in real time within about an hour by skipping traditional pre-treatment steps and using advanced imaging and artificial intelligence instead.

[Mona Arbab, MD MEd @MonaArbabMD]

Congrats to all that matched into radonc! We are so excited to work with Tessa, @BMGodinich and Hamza! Welcome to @UTSW_RadOnc family!

[Asal Rahimi M.D., M.S. @AsalRahimiMD]

@mleitc @utswcancer @UTSW_Surgery @nt_acs Congratulations!!

[A. Marilyn Leitch MD @mleitc]

Congratulations to Margaret Gallagher, Breast Surgical Oncology Fellow on winning Best Surgical Oncology Presentation at N. Tx American College of Surgeons Annual Mtg - surgical outcomes after PREOP single fraction partial breast XRT @utswcancer @UTSW_Surgery @nt_acs

[Kevin Albuquerque @GynRadonc]

In Collaboration with BrachyAcademy we are excited to announce our
hands-on Gyn Brachytherapy Training Program
email [email protected] https://t.co/sKA5xvnTAo

[Asal Rahimi M.D., M.S. @AsalRahimiMD]

@pnbarry Congrats!

[Asal Rahimi M.D., M.S. @AsalRahimiMD]

@ssuuvvaamm @ChandrakanthMv @K_Yadavir @DrHolmesLA @SpringerNature @JAMAOnc @dr_yakupergun @BapnaAjay @SuyogCancer @DrRishabhOnco Definitely on the horizon!

[Karamvir Yadav @K_Yadavir]

What if lumpectomy becomes optional?
❄️ FROST- freeze it
☢️ Rahimi- zap it once
90% near-pCR with a single radiation dose (Rahimi)
~1% 1-yr recurrence with cryoablation (FROST)
De-escalation ≠ compromise.
HR+ early BC is being redefined.
#ebc #MedTwitter #Oncology

[Asal Rahimi M.D., M.S. @AsalRahimiMD]

@KhashiFattah You are an incredible physician and UTSW is lucky to have you in the residency program. Looking forward to seeing all your accomplishments over the years. Thankyou for the kind words!

[Asal Rahimi M.D., M.S. @AsalRahimiMD]

@aguilera_md @utswcancer Thankyou @aguilera_md . The next generation of breast trials and other subsites look very bright for rad onc!

[Asal Rahimi M.D., M.S. @AsalRahimiMD]

@DrRishabhOnco Thank you for the excellent synopsis and review @DrRishabhOnco @OncoAlert @myESMO @ASCO @ESMO_Open @JAMANetworkOpen

[AuntMinnie.com @AuntMinnie]

Stereotactic partial breast irradiation could be a nonsurgical treatment option for some early-stage hormone receptor-positive (HR+) breast cancers #radiology @UTSWMedCenter @AsalRahimiMD https://t.co/SllhPmAena